Samil Pharmaceutical Co.,Ltd (KRX:000520)
10,280
-160 (-1.53%)
At close: Dec 5, 2025
KRX:000520 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 218,241 | 279,170 | 96,901 | 108,894 | 106,418 | 128,907 | Upgrade
|
| Market Cap Growth | -31.69% | 188.10% | -11.01% | 2.33% | -17.45% | 0.33% | Upgrade
|
| Enterprise Value | 376,193 | 420,498 | 272,367 | 265,842 | 202,048 | 200,995 | Upgrade
|
| Last Close Price | 10280.00 | 13150.00 | 6700.00 | 7800.00 | 7509.09 | 9184.43 | Upgrade
|
| PE Ratio | - | - | 58.25 | - | - | 96.16 | Upgrade
|
| PS Ratio | 1.01 | 1.27 | 0.49 | 0.61 | 0.79 | 1.05 | Upgrade
|
| PB Ratio | 1.53 | 1.59 | 0.76 | 0.87 | 1.62 | 2.03 | Upgrade
|
| P/TBV Ratio | 1.57 | 1.63 | 0.77 | 0.89 | 1.65 | 2.09 | Upgrade
|
| P/OCF Ratio | - | 107.79 | 8.25 | 26.22 | 75.11 | 16.58 | Upgrade
|
| EV/Sales Ratio | 1.75 | 1.91 | 1.39 | 1.48 | 1.51 | 1.63 | Upgrade
|
| EV/EBITDA Ratio | - | 57.52 | 23.03 | 29.52 | 39.53 | 18.72 | Upgrade
|
| EV/EBIT Ratio | - | 8739.66 | 42.16 | 66.19 | 505.45 | 30.74 | Upgrade
|
| EV/FCF Ratio | -40.96 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.15 | 0.85 | 1.38 | 1.27 | 1.91 | 1.49 | Upgrade
|
| Debt / EBITDA Ratio | - | 20.53 | 14.87 | 17.68 | 24.55 | 8.79 | Upgrade
|
| Asset Turnover | 0.56 | 0.57 | 0.54 | 0.62 | 0.64 | 0.66 | Upgrade
|
| Inventory Turnover | 4.02 | 4.13 | 4.27 | 4.59 | 3.53 | 3.18 | Upgrade
|
| Quick Ratio | 0.28 | 0.38 | 0.22 | 0.27 | 0.38 | 0.48 | Upgrade
|
| Current Ratio | 0.61 | 0.86 | 0.48 | 0.56 | 0.63 | 0.74 | Upgrade
|
| Return on Equity (ROE) | -17.04% | -3.70% | 1.31% | -0.03% | -8.27% | 2.13% | Upgrade
|
| Return on Assets (ROA) | -2.71% | 0.01% | 1.11% | 0.86% | 0.12% | 2.18% | Upgrade
|
| Return on Capital (ROIC) | -3.29% | 0.01% | 1.37% | 1.05% | 0.14% | 2.60% | Upgrade
|
| Return on Capital Employed (ROCE) | -7.20% | 0.00% | 3.20% | 1.80% | 0.40% | 7.00% | Upgrade
|
| Earnings Yield | -12.40% | -2.02% | 1.72% | -0.03% | -5.02% | 1.04% | Upgrade
|
| FCF Yield | -4.21% | -1.00% | -12.90% | -40.71% | -29.52% | -7.17% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 0.74% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 68.55% | Upgrade
|
| Buyback Yield / Dilution | -25.18% | -24.32% | -3.75% | -0.82% | -2.85% | -0.13% | Upgrade
|
| Total Shareholder Return | -25.18% | -24.32% | -3.75% | -0.82% | -2.85% | 0.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.